Introduction Burgeon Therapeutics was established in September 2020, co-founded by three veteran scientists from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. These founders include Nan Fajun, Xie Xin, and Li Jingya. Drawing from the founding team's extensive experience in interdisciplinary collaboration and leveraging the unique pharmaceutical research capabilities of academic institutions, the company is dedicated to building a sustainable platform for the discovery of novel drugs and their clinical development. |